Recombinant Anti-human CCNT1 Intrabody [Tat]
Recombinant anti-CCNT1 intrabody in fusion with HIV Tat works within cells to bind human CCNT1, expressed in 293T cells. Anti-hCyclinT1 intrabodies can be designed to block HIV-1 replication without causing cellular toxicity, and as a result, they may be useful agents for "intracellular immunization"-based gene therapy strategies for HIV-1 infection/AIDS.
| Supplier | Creative Biolabs |
|---|---|
| Product # | IAB-B032(T) |
| Pricing | Inquiry |
| Host | human |
| Target | CCNT1 |
| Species Reactivity | human |
| Type | scFv-Tat |
| Applications | Can be useful in applications such as: Enzyme-linked Immunosorbent Assay; Immunocytochemistry; Functional studies |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |